Report cover image

Global Human iPSCs Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 181 Pages
SKU # APRC20356599

Description

Summary

According to APO Research, The global Human iPSCs market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human iPSCs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Human iPSCs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Human iPSCs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Human iPSCs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Human iPSCs include Sumitomo Dainippon Pharma, ReproCELL, Pluricell Biotech, Ncardia, Fujifilm Holding Corporation (CDI), Fate Therapeutics, Inc, Cell Inspire Biotechnology and Astellas Pharma Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Human iPSCs, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Human iPSCs, also provides the revenue of main regions and countries. Of the upcoming market potential for Human iPSCs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human iPSCs revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Human iPSCs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Human iPSCs revenue, projected growth trends, production technology, application and end-user industry.

Human iPSCs Segment by Company

Sumitomo Dainippon Pharma
ReproCELL
Pluricell Biotech
Ncardia
Fujifilm Holding Corporation (CDI)
Fate Therapeutics, Inc
Cell Inspire Biotechnology
Astellas Pharma Inc
Human iPSCs Segment by Type

Skin
Blood Cells
Human iPSCs Segment by Application

Regenerative Medicine
Drug Development and Discovery
Academic Research
Toxicity Screening
Others
Human iPSCs Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human iPSCs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human iPSCs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human iPSCs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Human iPSCs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human iPSCs industry.
Chapter 3: Detailed analysis of Human iPSCs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human iPSCsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.

Table of Contents

181 Pages
1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Human iPSCs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Skin
1.2.3 Blood Cells
1.3 Market Analysis by Application
1.3.1 Global Human iPSCs Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
1.3.2 Regenerative Medicine
1.3.3 Drug Development and Discovery
1.3.4 Academic Research
1.3.5 Toxicity Screening
1.3.6 Others
1.4 Global Market Growth Prospects
1.5 Global Human iPSCs Growth Trends by Region
1.5.1 Global Human iPSCs Market Size by Region: 2020 VS 2024 VS 2031
1.5.2 Human iPSCs Market Size by Region (2020-2025)
1.5.3 Human iPSCs Market Size by Region (2026-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Human iPSCs Market Dynamics
2.1 Human iPSCs Industry Trends
2.2 Human iPSCs Industry Drivers
2.3 Human iPSCs Industry Opportunities and Challenges
2.4 Human iPSCs Industry Restraints
3 Competitive Landscape by Company
3.1 Global Human iPSCs Revenue by Company (2020-2025)
3.2 Global Human iPSCs Players Revenue Ranking, 2023 VS 2024 VS 2025
3.3 Global Human iPSCs Key Company Head office and Area Served
3.4 Global Human iPSCs Company, Product Type & Application
3.5 Global Human iPSCs Company Establishment Date
3.6 Market Competitive Analysis
3.6.1 Global Human iPSCs Market CR5 and HHI
3.6.2 Global Top 5 and 10 Human iPSCs Players Market Share by Revenue in 2024
3.6.3 2024 Human iPSCs Tier 1, Tier 2, and Tier 3
4 Human iPSCs Market by Type
4.1 Global Human iPSCs Market Size by Type (2020 VS 2024 VS 2031)
4.2 Global Human iPSCs Market Size by Type (2020-2031)
4.3 Global Human iPSCs Market Size Share by Type (2020-2031)
5 Human iPSCs Market by Application
5.1 Global Human iPSCs Market Size by Application (2020 VS 2024 VS 2031)
5.2 Global Human iPSCs Market Size by Application (2020-2031)
5.3 Global Human iPSCs Market Size Share by Application (2020-2031)
6 Company Profiles
6.1 Sumitomo Dainippon Pharma
6.1.1 Sumitomo Dainippon Pharma Comapny Information
6.1.2 Sumitomo Dainippon Pharma Business Overview
6.1.3 Sumitomo Dainippon Pharma Human iPSCs Revenue and Gross Margin (US$ Million) & (2020-2025)
6.1.4 Sumitomo Dainippon Pharma Human iPSCs Product Portfolio
6.1.5 Sumitomo Dainippon Pharma Recent Developments
6.2 ReproCELL
6.2.1 ReproCELL Comapny Information
6.2.2 ReproCELL Business Overview
6.2.3 ReproCELL Human iPSCs Revenue and Gross Margin (US$ Million) & (2020-2025)
6.2.4 ReproCELL Human iPSCs Product Portfolio
6.2.5 ReproCELL Recent Developments
6.3 Pluricell Biotech
6.3.1 Pluricell Biotech Comapny Information
6.3.2 Pluricell Biotech Business Overview
6.3.3 Pluricell Biotech Human iPSCs Revenue and Gross Margin (US$ Million) & (2020-2025)
6.3.4 Pluricell Biotech Human iPSCs Product Portfolio
6.3.5 Pluricell Biotech Recent Developments
6.4 Ncardia
6.4.1 Ncardia Comapny Information
6.4.2 Ncardia Business Overview
6.4.3 Ncardia Human iPSCs Revenue and Gross Margin (US$ Million) & (2020-2025)
6.4.4 Ncardia Human iPSCs Product Portfolio
6.4.5 Ncardia Recent Developments
6.5 Fujifilm Holding Corporation (CDI)
6.5.1 Fujifilm Holding Corporation (CDI) Comapny Information
6.5.2 Fujifilm Holding Corporation (CDI) Business Overview
6.5.3 Fujifilm Holding Corporation (CDI) Human iPSCs Revenue and Gross Margin (US$ Million) & (2020-2025)
6.5.4 Fujifilm Holding Corporation (CDI) Human iPSCs Product Portfolio
6.5.5 Fujifilm Holding Corporation (CDI) Recent Developments
6.6 Fate Therapeutics, Inc
6.6.1 Fate Therapeutics, Inc Comapny Information
6.6.2 Fate Therapeutics, Inc Business Overview
6.6.3 Fate Therapeutics, Inc Human iPSCs Revenue and Gross Margin (US$ Million) & (2020-2025)
6.6.4 Fate Therapeutics, Inc Human iPSCs Product Portfolio
6.6.5 Fate Therapeutics, Inc Recent Developments
6.7 Cell Inspire Biotechnology
6.7.1 Cell Inspire Biotechnology Comapny Information
6.7.2 Cell Inspire Biotechnology Business Overview
6.7.3 Cell Inspire Biotechnology Human iPSCs Revenue and Gross Margin (US$ Million) & (2020-2025)
6.7.4 Cell Inspire Biotechnology Human iPSCs Product Portfolio
6.7.5 Cell Inspire Biotechnology Recent Developments
6.8 Astellas Pharma Inc
6.8.1 Astellas Pharma Inc Comapny Information
6.8.2 Astellas Pharma Inc Business Overview
6.8.3 Astellas Pharma Inc Human iPSCs Revenue and Gross Margin (US$ Million) & (2020-2025)
6.8.4 Astellas Pharma Inc Human iPSCs Product Portfolio
6.8.5 Astellas Pharma Inc Recent Developments
7 North America
7.1 North America Human iPSCs Market Size (2020-2031)
7.2 North America Human iPSCs Market Size by Type
7.2.1 North America Human iPSCs Market Size by Type (2020-2025)
7.2.2 North America Human iPSCs Market Size by Type (2026-2031)
7.2.3 North America Human iPSCs Market Share by Type (2020-2031)
7.3 North America Human iPSCs Market Size by Application
7.3.1 North America Human iPSCs Market Size by Application (2020-2025)
7.3.2 North America Human iPSCs Market Size by Application (2026-2031)
7.3.3 North America Human iPSCs Market Share by Application (2020-2031)
7.4 North America Human iPSCs Market Size by Country
7.4.1 North America Human iPSCs Market Size by Country (2020 VS 2024 VS 2031)
7.4.2 North America Human iPSCs Market Size by Country (2020-2025)
7.4.3 North America Human iPSCs Market Size by Country (2026-2031)
7.4.4 North America Human iPSCs Market Share by Country (2020-2031)
7.4.5 United States
7.4.6 Canada
7.4.7 Mexico
8 Europe
8.1 Europe Human iPSCs Market Size (2020-2031)
8.2 Europe Human iPSCs Market Size by Type
8.2.1 Europe Human iPSCs Market Size by Type (2020-2025)
8.2.2 Europe Human iPSCs Market Size by Type (2026-2031)
8.2.3 Europe Human iPSCs Market Share by Type (2020-2031)
8.3 Europe Human iPSCs Market Size by Application
8.3.1 Europe Human iPSCs Market Size by Application (2020-2025)
8.3.2 Europe Human iPSCs Market Size by Application (2026-2031)
8.3.3 Europe Human iPSCs Market Share by Application (2020-2031)
8.4 Europe Human iPSCs Market Size by Country
8.4.1 Europe Human iPSCs Market Size by Country (2020 VS 2024 VS 2031)
8.4.2 Europe Human iPSCs Market Size by Country (2020-2025)
8.4.3 Europe Human iPSCs Market Size by Country (2026-2031)
8.4.4 Europe Human iPSCs Market Share by Country (2020-2031)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Human iPSCs Market Size (2020-2031)
9.2 China Human iPSCs Market Size by Type
9.2.1 China Human iPSCs Market Size by Type (2020-2025)
9.2.2 China Human iPSCs Market Size by Type (2026-2031)
9.2.3 China Human iPSCs Market Share by Type (2020-2031)
9.3 China Human iPSCs Market Size by Application
9.3.1 China Human iPSCs Market Size by Application (2020-2025)
9.3.2 China Human iPSCs Market Size by Application (2026-2031)
9.3.3 China Human iPSCs Market Share by Application (2020-2031)
10 Asia (Excluding China)
10.1 Asia Human iPSCs Market Size (2020-2031)
10.2 Asia Human iPSCs Market Size by Type
10.2.1 Asia Human iPSCs Market Size by Type (2020-2025)
10.2.2 Asia Human iPSCs Market Size by Type (2026-2031)
10.2.3 Asia Human iPSCs Market Share by Type (2020-2031)
10.3 Asia Human iPSCs Market Size by Application
10.3.1 Asia Human iPSCs Market Size by Application (2020-2025)
10.3.2 Asia Human iPSCs Market Size by Application (2026-2031)
10.3.3 Asia Human iPSCs Market Share by Application (2020-2031)
10.4 Asia Human iPSCs Market Size by Country
10.4.1 Asia Human iPSCs Market Size by Country (2020 VS 2024 VS 2031)
10.4.2 Asia Human iPSCs Market Size by Country (2020-2025)
10.4.3 Asia Human iPSCs Market Size by Country (2026-2031)
10.4.4 Asia Human iPSCs Market Share by Country (2020-2031)
10.4.5 Japan
10.4.6 South Korea
10.4.7 Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 South America, Middle East & Africa
11.1 South America, Middle East & Africa Human iPSCs Market Size (2020-2031)
11.2 South America, Middle East & Africa Human iPSCs Market Size by Type
11.2.1 South America, Middle East & Africa Human iPSCs Market Size by Type (2020-2025)
11.2.2 South America, Middle East & Africa Human iPSCs Market Size by Type (2026-2031)
11.2.3 South America, Middle East & Africa Human iPSCs Market Share by Type (2020-2031)
11.3 South America, Middle East & Africa Human iPSCs Market Size by Application
11.3.1 South America, Middle East & Africa Human iPSCs Market Size by Application (2020-2025)
11.3.2 South America, Middle East & Africa Human iPSCs Market Size by Application (2026-2031)
11.3.3 South America, Middle East & Africa Human iPSCs Market Share by Application (2020-2031)
11.4 South America, Middle East & Africa Human iPSCs Market Size by Country
11.4.1 South America, Middle East & Africa Human iPSCs Market Size by Country (2020 VS 2024 VS 2031)
11.4.2 South America, Middle East & Africa Human iPSCs Market Size by Country (2020-2025)
11.4.3 South America, Middle East & Africa Human iPSCs Market Size by Country (2026-2031)
11.4.4 South America, Middle East & Africa Human iPSCs Market Share by Country (2020-2031)
11.4.5 Brazil
11.4.6 South Africa
11.4.7 Saudi Arabia
11.4.8 Turkey
11.4.9 Argentina
11.4.9 UAE
11.4.9 Egypt
11.4.9 Chile
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.